CCL Industries (CCL-B) Q4 2024 earnings summary

Executive summary

• 2024 sales reached $7,245.0 million, up 9% year-over-year, with Q4 sales at $1,812.5 million and 6.8% organic growth, 1.4% from acquisitions, and 0.8% from currency translation.

• Net earnings for 2024 were $843.1 million, including a $78.1 million non-taxable revaluation gain and a $95.0 million goodwill impairment charge; Q4 net earnings were $179.8 million.

• Adjusted basic EPS for 2024 was $4.32, up 14.9% from 2023; Q4 adjusted EPS was $1.02.

• Free cash flow from operations for 2024 was $606.5 million, up from $559.6 million in 2023.

• Nine acquisitions since January 2023, including full Pacman JV consolidation, contributed to growth.

Financial highlights

• Operating income for 2024 rose 13% to $1,142.3 million, with a 15.8% operating margin.

• Adjusted EBITDA for 2024 was $1,497.1 million, with a 20.7% margin.

• Net debt at year-end was $1,618.9 million, leverage ratio at 1.08x EBITDA, with $828.7 million cash and $956.7 million undrawn credit.

• $407 million returned to shareholders in 2024 via $200.6 million in buybacks and $206.4 million in dividends; payout ratio was 27%.

• Capital spending was $457.4 million in 2024, with $485 million planned for 2025.

Outlook and guidance

• 2025 capex forecasted at $485 million, focused on greenfield projects and capacity additions.

• Free cash flows in 2025 expected to remain strong, supporting global expansion.

• Early 2025 order trends are stable, but management remains cautious due to macroeconomic and geopolitical uncertainties.

• Foreign exchange expected to be a modest tailwind in 2025.

• Board declared a 10.3% increase in quarterly dividend to $0.32 per Class B share.